Grey Wolf Therapeutics

Developer of small molecule based therapeutics for cancer treatment

placeOxford, England, United Kingdom calendar_todayFounded 2017 groups7 employees language greywolftherapeutics.com

Registered entities

Investor mix

10 investors on record; lead investors include Pfizer, Earlybird, Andera Partners, Canaan.

Investor typeCountShare
Venture capital550%
Private equity110%
Bank & private debt110%
Other / undisclosed330%
Coming soon